Effects of Palmijihwang-hwan: A Herbal Formula on the Pharmacokinetics of Tamsulosin in Rats

ABSTRACT

Background: Tamsulosin is an α1-adrenoceptor antagonist used to treat lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Palmijihwang-hwan (PMJHH) is a traditional herbal formula for treating prostatic disorders and is often used with tamsulosin for treating LUTS/BPH. The co-administration of herbal medicines and conventional drugs increases the potential for clinically considerable herb−drug interactions. Hence, it is important to evaluate the safety of such combinations of drugs. This study aimed to investigate the influence of PMJHH on the pharmacokinetics of tamsulosin in rats. Materials and Methods: We developed and validated a simple and rapid method to determine the plasma levels of tamsulosin in rats using an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) system. After oral administration of tamsulosin (2 mg/kg), either alone or in combination with PMJHH (930 mg/kg), to rats, blood samples were collected at various times and used for pharmacokinetic studies. The pharmacokinetic parameters were analyzed using a non-compartmental model. Results: Compared to tamsulosin alone, co-administration of PMJHH had no significant effects on any pharmacokinetic parameters of tamsulosin, including maximal plasma concentration (Cmax), time to Cmax (Tmax), terminal elimination half-life (t1/2), AUC from time 0 to the last observation (AUC0−t), mean residence from time 0 to infinity (MRT0−∞), apparent oral clearance (Cl/F), and apparent volume of distribution during terminal elimination (Vz/F). Conclusion: The pharmacokinetics of tamsulosin were not affected by the co-administration of PMJHH. Our findings, therefore, validate the safety of the combination of tamsulosin and PMJHH commonly used for treating LUTS/BPH.

KEYWORDS

• Benign prostatic hyperplasia
• herb−drug interaction
• Palmijihwang-hwan
• pharmacokinetics

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/09731296231158703Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 19, ISSUE 2In vitro Antioxidant and Anti-inflammatory Effects of Erythroxylum cuneatum Leaf Extract on Oxidized Low-density Lipoprotein-stimulated Human Aortic Endothelial CellsSiti Khadijah Adam, Nitya Shanmugam, Sharlina Mohamad, Shamima Abd Rahman, Mohamad Aris Mohd Moklas · pp. 203–213Original ArticleSame type: Article
• Article · VOLUME 19, ISSUE 2Ethacridine Regulation of JAK/STAT/ERK Signaling Pathway in Colon Cancer Cells SW620: In vitro ApproachHui Zhang, Hui Yang, Wei Wei, Jing Zhao, Annamalai Vijayalakshmi, Minhong Wang · pp. 214–221Original ArticleSame type: Article
• Article · VOLUME 19, ISSUE 2LC-MS/MS-based Targeted Metabolomic Profiling of Aqueous and Hydro-alcoholic Extracts of Pistacia integerrima Linn., Quercus infectoria Olivier and Terminalia chebula RetzAnil Kumar Saini, Laxman Sawant, Sultan Zahiruddin, Dhiraj Shrivastva, Ranjan Mitra, Rajiva Kumar Rai, Sayeed Ahmad · pp. 222–230Original ArticleSame type: Article
• Article · VOLUME 19, ISSUE 2Amelioration of AlCl3-induced Memory Loss in the Rats by an Aqueous Extract of Guduchi, a Medhya RasayanaShrirang B. Jamadagni, Pooja M. Ghadge, Mukul S. Tambe, Marimuthu Srinivasan, Goli Penchala Prasad, Pallavi S. Jamadagni, Shyam Baboo Prasad, Sharad D. Pawar, Arun M. Gurav, Sudesh N. Gaidhani, Y. R. Sanjay Kumar, Narayanam Srikanth · pp. 231–243Original ArticleSame type: Article